Dale and Betty Bumpers Vaccine Research Center National Institute of Allergy and Infectious Diseases National Institutes of Health Richard A. Koup Vaccine.

Slides:



Advertisements
Similar presentations
LYMPHOID ORGNS Function - maturation - differentiation - proliferation
Advertisements

Supplementary Figure S1Wang et. al. Supplementary Figure S1: (a) Purity of transferred Tconv. Tconv (CD4 + CD45RB hi CD25 ) were sorted from the spleen.
Metabolic consequences of HIV-induced inflammation Jacqueline Capeau INSERM U938, Université Pierre et Marie Curie Faculté de Médecine, site Saint-Antoine,
Miriam Lichtner Dipartimento di Malattie Infettive e Sanità Pubblica Sapienza Università di Roma Polo Pontino Componente dell Italian National Focal Point.
CEACHRUCNRSCPUINRAINRIAINSERMINSTITUT PASTEURIRD 1 CEACHRUCNRSCPUINRAINRIAINSERMINSTITUT PASTEURIRD Skin targeting for vaccine efficacy Laboratory of «
Phases of HIV/AIDS 1. Infection 2. Window period 3. Seroconversion 4. Asymptomatic period 5. HIV/AIDS - related illness 6. AIDS.
Impact of Tryptophan Catabolism on CD4+ T Cell Recovery and Mortality in HIV-infected Ugandans Initiating ART Peter W. Hunt, Sheri Weiser, Yong Huang,
Immunity to Infectious Diseases
Pathogenesis of HIV disease and markers of progression Anjie Zhen, PhD.
Project Inform © Immune Pathogenesis of HIV Pathogenesis: The way that something causes disease. Immune pathogenesis is how the virus (HIV) interacts.
Immunobiology: The Immune System in Health & Disease Sixth Edition
Immunobiology: The Immune System in Health & Disease Sixth Edition
Immunobiology: The Immune System in Health & Disease Sixth Edition
2014 “Towards an HIV Cure” symposium Melbourne Genetically Characterizing the Role of Cell Proliferation in Maintaining Persistent HIV during Effective.
T follicular helper cells in HIV infection
Chapter15 B cell mediated immune response. B cells mediated immune response Humoral immunity(HI) or antibody mediated immunity: The total immunological.
Changes in Antibodies Class switch recombination mutation, selection
Comparison between Pathogenic and Nonpathogenic SIV Infections and Focus on Mucosal Tissue Compartment Reveal a Critical Role for the.
Immunity to Infectious Diseases BIOS 486A/586A K.J.Goodrum 2006.
Dale and Betty Bumpers Vaccine Research Center National Institute of Allergy and Infectious Diseases National Institutes of Health Richard A. Koup, MD.
Probiotic and IL-21 Treatment Promotes Th17 Cell Recovery in ARV-Treatment of Pigtail Macaques Alexandra M. Ortiz Laboratory of Jason Brenchley July 23,
Slide 1 of 10 From DC Douek, MD, at Atlanta, GA: April 10, 2013, IAS-USA. IAS–USA Daniel C. Douek, MD, PhD Bethesda, Maryland Immune Activation, HIV Persistence,
CD4+ memory stem cells (T SCM ) in pathogenic and non- pathogenic SIV infections Guido Silvestri, MD Yerkes National Primate Research Center Emory University.
Target cell availability dictates mother-to-infant transmission of SIV
Studies of HIV Eradication: a Case for Using NHP Models Guido Silvestri, MD Yerkes National Primate Research Center Emory University School of Medicine.
HIV-1 TRANSMISSION FROM SEMEN TO CERVICO-VAGINAL TISSUE EX VIVO Andrea Introini 1, Christophe Vanpouille 1, Andrea Lisco 1, Jean-Charles Grivel, Arshi.
Characterization of persistent HIV-1 in a broad spectrum of CD4 + T-cells isolated from peripheral blood, bone marrow, lymphoid tissue and gut associated.
Viral Tissue Reservoirs Are Determined Early and Little Viral RNA Is Detected during Suppression in the Macaque Model Zandrea Ambrose, Ph.D. Division of.
Mirko Paiardini, PhD Emory University, YNPRC
Primary HIV-1 Infection Pathogenesis, Diagnosis, and Treatment Summary of Evidence Martin Markowitz M.D. Clinical Director and Staff Investigator Aaron.
Immunology molecular medicine 3 Conleth Feighery.
HIV-1 infection decreases CD127 and PD1 expression on duodenal CD8+T cells Liliana Belmonte, PhD Academia Nacional de Medicina Buenos Aires, Argentina.
CDER Meeting: Surrogate Markers of Immunity Presenter: Judith A. Britz, Ph.D. October 16, 2000.
T-CELL MEMORY Central Effector. 1781:Measles epidemic in the Faroe Islands No measles for 65 years 1846: Measles epidemic Those individuals, who were.
Chapter 4 and 5 Ig study questions (Tu): Can you name at least four ways in which CSR and V(D)J recombination differ? What are the substrates (what genes,
HIV pathogenesis The course of HIV infection 1. Acute Phase 2. Intermediate (asymptomatic) phase -viral load stabilizes at a “set point”. 3. Late (symptomatic)
Hye Kyung Chung Ph.D Advanced BioScience Laboratories, Inc Transcription Profiling of CD4+ T Cells in Rhesus Macaques that Infected with Simian -Human.
Lecture 13 Immunology and disease: parasite antigenic diversity.
HUMORAL IMMUNE RESPONSES HAVE LITTLE EFFECT ON CONTROLLING VIREMIA DURING SIVagm INFECTION OF AFRICAN GREEN MONKEYS Thaidra Gaufin Division of Microbiology.
B Cell Activation Abul K. Abbas UCSF FOCiS.
Routine vaccination and maintenance of serological memory in HIV infected children Moderators: Berhanu Gudeta, Ethiopia Francesca Chiodi, Sweden Cell Damage.
The impact of treatment duration on defective and expanded identical HIV genomes in T cell subsets from peripheral blood and tissues Eunok Lee.
HIV-infected patients, and have proliferative defects
Rapporteur Report – Track A Basic and Translational Sciences
Washington State University
HIV Cure: Current Status and Future Perspectives
B Cells and Antibodies Abul K. Abbas UCSF FOCiS.
Chapter 10 Ig study questions:
SIV-specific CD8+ T cells express high levels of PD1 and cytokines but have impaired proliferative capacity in acute and chronic SIVmac251 infection by.
Immunological memory Topics Immune regulation  T cells
KEY CONCEPT Some viral diseases can be prevented with vaccines.
Coinfection With HIV-1 and HCV—A One-Two Punch
The Aging Liver in the Aging HIV and HCV Patients
Volume 27, Issue 4, Pages (October 2007)
Immune System Practice Test
Steven G. Deeks, Russell Tracy, Daniel C. Douek  Immunity 
Volume 45, Issue 3, Pages (September 2016)
Jason M. Brenchley, Guido Silvestri, Daniel C. Douek  Immunity 
HIV and Tfh Cells: Circulating New Ideas to Identify and Protect
Immunity to Infectious Diseases
Immune System Practice Test
Coinfection With HIV-1 and HCV—A One-Two Punch
Unit 7: Infectious Diseases
Volume 18, Issue 3, Pages (March 2003)
The germinal center reaction
CD8 T cell memory alters the immune profile in enhanced HLH without altering viral load. CD8 T cell memory alters the immune profile in enhanced HLH without.
Steven G. Deeks, Russell Tracy, Daniel C. Douek  Immunity 
KEY CONCEPT Some viral diseases can be prevented with vaccines.
KEY CONCEPT Some viral diseases can be prevented with vaccines.
Fig. 3 Viral loads and viral DNA in anti-α4β7 antibody–treated rhesus macaques that initiated ART during chronic SIVmac251 infection (study 2). Viral loads.
Presentation transcript:

Dale and Betty Bumpers Vaccine Research Center National Institute of Allergy and Infectious Diseases National Institutes of Health Richard A. Koup Vaccine Research Center Lymph node structure and HIV-1 infection: T cell immunopathogenesis

Background HIV replication is active in lymph nodes throughout the course of HIV infection HIV leads to an initial hypertrophy, followed by involution of lymphoid tissues (Tim Schacker) SIV infection in rhesus macaques has a similar pathogenesis to HIV infection in humans (Guido Silvestri) and can be used to study the immuno- pathogenesis of HIV infection in lymph nodes In this talk I will concentrate on using acute and early SIV infection of rhesus macaques to model HIV pathogenesis in lymph nodes

Janeway’s Immunobiology (8 th Edition) The Lymph Node has a Complicated Structure

Simplified LN Structure Paracortical Area (T cells) Lymphoid Follicle (B cells) Germinal Center (B and T cells) Light Zone (T/B cell interaction) Dark Zone (B cell proliferation)

Simplified LN Structure – HIV Infection UninfectedInfected - Early Germinal Center Hypertrophy (increased germinal center T cells) Loss of non- germinal center T cells Infected - Late

Outline Virus replication in LN during acute/early HIV/SIV infection Changes in CD4 T cell populations in LNs during acute/early HIV/SIV replication Underlying mechanisms Non-T cell consequences

SIV as a model for HIV infection Nature 434:1093-7, 2005

Plasma Viral Load (Log 10 ) Acute Infection: Plasma Viral Loads

CD4 T Cells, % of CD3 + Total CD4 Cell Dynamics

Mesenteric LN PBMC DaysPost-infection CD4 Memory, % of CD3 + Memory CD4 T Cell Dynamics Early expansion at d. 3 Loss of ~80% of cells by d. 17

Cell-Associated Viral Loads

These data do not take into account structural localization within the LN Where is the virus replicating with respect to the paracortical T cell zone and the light zone of the germinal center? What is happening to CD4 T cell frequency in these areas during acute and early SIV infection? Paracortical T cell zone Light zone of the germinal center

Surface markers can distinguish CD4 T cells from these different areas Paracortical T cell zone Light zone of the germinal center CD95 CD28 CD8 CD4 CD3 Aqua FSC-A FSC-H PD-1 CCR

Where does SIV replicate? PD-1 CCR Early SIV (>2 months) Acute SIV (3-21 days) SIV Gag DNA (copies/cell) p= p= ICOS CD150 Paracortical T cell zone Light zone of the germinal center Would expect to see depletion of CD4 T cells in germinal centers

SIV: Relative accumulation of CD4 T cells in GCs PD-1 CCR7 CCR7 high PD-1 low CCR7 high/low PD-1 dim T FH % of CM CD4 T cells SIV acute SIV early SIV -

CD4 PD1 Ki-67 Michael Gerner, Ron Germain Light zone: T - B cell interaction Dark zone: B cell proliferation Accumulation of GC CD4 T cells during SIV infection: Abundant GCs with retained architecture

Mechanism? UninfectedInfected - Early ?

No correlation between VLs and percent GC T cells during SIV infection Percent GC T cells in LN Viral Loads

GC T cells % of CM CD4 T cells Accumulation of GC T cells is associated with general immune activation (sCD14) p= p= p= sCD14 (x10 6 pg/ml) SIV acute SIV early (high % of T FH ) SIV - SIV early (low % of T FH )

SIV: Relative accumulation of GC T cells IL-6 signaling drives the up-regulation of Bcl-6 and enhanced T cell responses that are seen during chronic LCMV infection in mice. Does IL-6 production drive the accumulation of GC T cells during early SIV infection in monkeys?

SIV - SIV + (early) p= Increase in the IL-6/IL-6R axis is associated with GC T cell accumulation during SIV infection Plasma IL-6 (pg/ml) p= Percent GC T cells in LN IL6Ra on GC T cells (MFI)

Mechanism? UninfectedInfected - Early IL-6 2) Altered phospho STAT (3>1) 3) GC T cell differentiation 4) Immune activation 1) Petrovas et al, J. Clin. Invest., 2012

SIV - SIV chronic (low % GC T cells) SIV chronic (high % GC T cells) p= Aqua SSC CD20 CD3 PNA IgG PBMC LN PNA high IgG low PNA high IgG high SIV - SIV + low T SIV + high T GC T cells are T FH that influence B cells differentiation and antibody production SIV chronic (low % GC T cells) SIV chronic (high % GC T cells) gp120 p=0.051 SIV-specific IgG (titer, x10 4 )

Conclusions HIV/SIV replication is profound during acute infection This leads to a massive depletion of memory CD4 T cells in the LN and gut CD4 T cell depletion from the gut leads to microbial translocation and general immune activation (discussed elsewhere) Immune activation promotes differentiation of T cells in the LN which move to and accumulate in the GCs (lymphoid hypertrophy) – Non-pathogenic SIV controls immune activation Continued immune activation ultimately leads to fibrosis of the lymph nodes

Simplified LN Structure – HIV Infection UninfectedInfected - Early Germinal Center Hypertrophy (increased germinal center T cells) Loss of non- germinal center T cells Infected - Late Direct infection: CD4 depletion Immune activation: GC hypertrophy followed by fibrosis

Dale and Betty Bumpers Vaccine Research Center National Institute of Allergy and Infectious Diseases National Institutes of Health Costas Petrovas Takuya Yamamoto Kristin Boswell Joseph Casazza Rob Paris David Ambrozak Immunology Laboratory NIAID/NCI Collaborators Michael Gerner Ron Germain Human Immunology Section Netanya Sandler Daniel Douek ImmunoTechnology Section Mario Roederer Lab Animal Medicine John-Paul Todd Srinivas Rao